NCT04989387
Study of INCA 0186 in Subjects With Advanced Solid Tumors treatment 1 active_not_recruiting NCT05537987
Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00729833
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors treatment 1 terminated NCT04492033
A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients treatment 1 / 2 active_not_recruiting NCT02734433
Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors treatment 1 completed NCT01940133
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 treatment 1 completed NCT00879554
A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00692354
Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours treatment 1 completed NCT04727554
Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors treatment 1 completed NCT03852251
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma treatment 1 / 2 completed NCT04332653
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT03968653
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors treatment 1 recruiting NCT00827177
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT06158477
A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT00963547
A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015) treatment 1 terminated NCT01340547
Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors treatment 1 unknown_status NCT03133247
A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients treatment 1 completed NCT01714947
Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib treatment 1 completed NCT00546247
A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) treatment 1 / 2 terminated NCT02266745
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts treatment 2 active_not_recruiting NCT01898845
A Phase I Study of LEE011 in Asian Patients treatment 1 completed NCT01017198
Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors treatment 1 completed NCT02261298
ONO-4538 Phase I Study in Patients With Solid Tumor treatment 1 completed NCT02354898
A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma treatment 1 completed NCT02729298
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors treatment 1 completed NCT06131398
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors basic_science 1 recruiting NCT05688605
A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT01155505
Lenalidomide and Paclitaxel in Advanced Solid Tumors treatment 1 unknown_status NCT01302405
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors treatment 1 terminated NCT05533697
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT01235897
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies treatment 1 completed NCT05067283
A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001) treatment 1 recruiting NCT00915083
A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors. treatment 1 completed NCT00591383
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors treatment 1 unknown_status NCT05678283
A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors treatment 1 withdrawn NCT02456883
Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Tumors treatment 1 completed NCT04185883
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) treatment 1 recruiting NCT05649761
A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00419328
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors treatment 1 completed NCT00861328
Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin treatment 1 completed NCT01148628
Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT01178411
An Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) Protocols treatment 1 / 2 completed NCT01413893
An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors basic_science 1 completed NCT04618393
A Study of EMB-02 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT05502393
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT01163071
A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 terminated NCT02880371
A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT00635778
A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002) treatment 1 completed NCT03993678
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. No drug interventions treatment 1 / 2 recruiting NCT04921878
A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors treatment 1 completed NCT04492488
A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer treatment 1 / 2 unknown_status NCT01494688
A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors treatment 1 completed NCT06520488
A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT01253707
A Study of AMG 337 in Subjects With Advanced Solid Tumors treatment 1 completed NCT03077607
A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors treatment 1 completed NCT01529307
First in Human Trial of TAS266 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05941507
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04481009
A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors treatment 1 / 2 completed NCT03082209
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies treatment 1 completed NCT05701709
Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05349409
A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers treatment 2 enrolling_by_invitation NCT01226056
Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets treatment 1 / 2 suspended NCT00603356
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors treatment 1 completed NCT01482156
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors treatment 1 completed NCT03568656
Study to Evaluate CCS1477 in Advanced Tumours treatment 1 / 2 recruiting NCT06094556
An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04058756
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments treatment 1 active_not_recruiting NCT02551185
ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04157985
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors treatment 3 recruiting NCT01050985
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer treatment 1 completed NCT00688415
Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer other 1 completed NCT02743637
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors treatment 1 completed NCT04518137
A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH) treatment 2 terminated NCT05906537
SKB410 for Injection in Solid Tumors No drug interventions treatment 1 recruiting NCT05378737
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection treatment 1 recruiting NCT01363232
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients treatment 1 completed NCT05278832
A Study of QLS31905 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT03461952
Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe) treatment 2 terminated NCT00522652
Phase I Trial of PX-478 treatment 1 completed NCT03472352
Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors No drug interventions treatment 1 unknown_status NCT02564900
Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors treatment 1 completed NCT03934359
A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT03595059
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors treatment 1 active_not_recruiting NCT05508659
A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT03379259
Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors treatment 1 / 2 terminated NCT06331559
Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors treatment 1 recruiting NCT03415659
Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00793975
Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy Not Available 1 completed NCT04565275
A Study of ICP-192 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03889275
A Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid Tumors treatment 1 completed NCT05407675
A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT00730470
Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02122770
Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors treatment 1 completed NCT00997399
Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function other 1 completed NCT05287399
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05267899
A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00788099
Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT05775406
Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors treatment 1 recruiting NCT05564806
Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma No drug interventions treatment 1 recruiting NCT00514306
Study of Intermittent OSI-906 Dosing treatment 1 completed NCT06329206
A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01248949
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors treatment 1 completed NCT04487236
Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors treatment 1 recruiting NCT04811118
The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere treatment 1 unknown_status NCT05063318
Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT01159418
LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors treatment 1 unknown_status NCT04087018
Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors treatment 1 completed NCT03429218
First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01406119
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors treatment 1 completed NCT05718219
Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Escalating Doses of SIM0348 as a Single Agent in Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT01381341
To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. basic_science 1 completed NCT06040541
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors No drug interventions treatment 1 recruiting NCT04049617
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05457517
A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06167317
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors treatment 1 recruiting NCT01668017
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy treatment 1 terminated NCT00550017
A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) treatment 1 / 2 terminated NCT03387917
TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04882917
First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410) treatment 1 completed NCT01625234
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04716634
Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors treatment 2 completed NCT01571024
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer treatment 1 completed NCT02611024
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors treatment 1 / 2 recruiting NCT05473624
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05836324
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00524524
An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors treatment 1 completed NCT05944224
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. treatment 1 / 2 recruiting NCT02460224
Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. treatment 1 / 2 completed NCT00949624
CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors treatment 1 completed NCT02578316
A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. treatment 1 completed NCT04387916
A Study of KC1036 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01830816
Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment treatment 1 completed NCT00473616
Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan treatment 1 terminated NCT01472016
Study of ABT-700 in Subjects With Advanced Solid Tumors treatment 1 completed NCT02437916
Safety Study of AMG 228 to Treat Solid Tumors No drug interventions treatment 1 terminated NCT05153096
Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT05904496
A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT00831896
Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies No drug interventions treatment 1 completed NCT05719558
A Study of ASP1002 in Adults for Treatment of Solid Tumors No drug interventions treatment 1 recruiting NCT02040558
Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00951158
A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors No drug interventions basic_science 1 terminated NCT00842335
A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT05487235
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT02671435
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors treatment 1 / 2 active_not_recruiting NCT00618735
Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors treatment 1 completed NCT02997163
An Open-Label Pharmacokinetics and Safety Study of Talazoparib treatment 1 completed NCT02210663
A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors treatment 1 completed NCT01110486
ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors treatment 1 completed NCT06299839
PAS-004 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04262739
MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04778839
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. treatment 1 recruiting NCT05072522
A Study of SKLB1028 in Patients With Advanced Solid Tumor No drug interventions treatment 1 unknown_status NCT05541822
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation No drug interventions treatment 2 recruiting NCT03260322
A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 completed NCT01004822
A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05881525
NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors treatment 1 recruiting NCT05865925
Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors treatment 1 / 2 enrolling_by_invitation NCT05010525
A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT01132625
Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan treatment 1 completed NCT01293630
A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors treatment 1 completed NCT01226030
Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors treatment 1 unknown_status NCT02609230
A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma treatment 1 completed NCT02301130
Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors treatment 1 completed NCT05781048
A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04362748
Study of AMG 256 in Adult Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03070548
A Study of Talazoparib in Patients With Advanced Solid Tumors treatment 1 completed NCT05134948
A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT00996957
Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma treatment 1 completed NCT03000257
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors treatment 1 completed NCT05904457
A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer treatment 2 recruiting NCT03797326
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) treatment 2 active_not_recruiting NCT00932126
This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors treatment 1 terminated NCT04069026
A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer No drug interventions treatment 1 completed NCT02432326
A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors treatment 1 completed NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03057366
A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors other 1 completed NCT01867866
Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone treatment 1 completed NCT05554666
A Study of ASKG315 in Patients With Advanced Solid Tumors. No drug interventions treatment 1 recruiting NCT01576666
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors other 1 completed NCT05254665
A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors treatment 2 unknown_status NCT05287165
Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms No drug interventions treatment 0 unknown_status NCT00938574
Study With Atu027 in Patients With Advanced Solid Cancer No drug interventions treatment 1 completed NCT00877474
Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors treatment 1 completed NCT01286974
A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors. basic_science 1 terminated NCT01791374
Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ treatment 1 completed NCT06024174
A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors treatment 1 / 2 terminated NCT03692520
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT03191682
A First-in-Human Study of PRL3-ZUMAB No drug interventions treatment 1 unknown_status NCT04312282
The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors treatment 1 terminated NCT03010982
Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors treatment 1 completed NCT05029882
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab treatment 1 recruiting NCT02546531
Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer treatment 1 completed NCT05888831
A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06134531
First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06028373
A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas No drug interventions treatment 1 recruiting NCT06459973
A Clinical Study of YL205 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01352273
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations treatment 1 completed NCT01867073
A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours No drug interventions Not Available Not Available unknown_status NCT05864573
Study of ZGGS15 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04095273
Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug treatment 1 completed NCT03463473
A Phase I Study of MSB2311 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT05508373
A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00959127
A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer treatment 1 completed NCT05214976
A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients treatment 2 enrolling_by_invitation NCT06500676
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations No drug interventions treatment 1 / 2 recruiting NCT02997176
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) treatment 1 completed NCT05972460
IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04675060
Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules No drug interventions treatment 1 unknown_status NCT02073994
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation treatment 1 completed NCT04293094
Study of AMG 650 in Adult Participants With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00620594
A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer treatment 1 completed NCT05667194
Phase 1 Trial of KH617 No drug interventions treatment 1 recruiting NCT03991494
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer basic_science 1 completed NCT03700294
Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01433991
A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2) treatment 1 / 2 terminated NCT06242691
Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT00519662
Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors treatment 1 completed NCT04808362
Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours No drug interventions treatment 1 / 2 terminated NCT02057380
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial treatment 2 completed NCT06413680
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT06209580
AMT-253 in Patients With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT05498480
Study of Relatlimab in Combination With Nivolumab in Chinese Participants treatment 1 completed NCT05543629
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT03497429
A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors other 1 completed NCT03665129
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors treatment 1 terminated NCT02448589
An Investigation of TAS-119 Monotherapy No drug interventions treatment 1 terminated NCT01946789
A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors treatment 1 completed NCT01520389
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment treatment 1 completed NCT01064089
Dose Escalation of HSP990 in Japan/Korea No drug interventions treatment 1 terminated NCT00935844
Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma treatment 1 completed NCT00881244
Study of AS1411 in Advanced Solid Tumours treatment 1 completed NCT05320640
Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors treatment 1 / 2 recruiting NCT03382340
IMX-110 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) treatment 2 recruiting NCT02134067
Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors treatment 1 terminated NCT05853367
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) treatment 1 recruiting NCT04450901
Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT03117101
Study of the AL3810 in the Treatment of Advanced Solid Tumor treatment 1 completed NCT00712504
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer treatment 1 completed NCT01421004
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors treatment 1 completed NCT05549804
A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03577704
The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. treatment 1 / 2 completed NCT02454972
Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors treatment 2 completed NCT02197572
Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors treatment 1 completed NCT05685472
MEDI5752 in Japanese Patients With Advanced Solid Tumors. treatment 1 active_not_recruiting NCT04309968
Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04768868
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06092268
A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT05571969
Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT03490669
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors No drug interventions treatment 1 completed NCT01989546
Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations treatment 1 / 2 completed NCT04746612
First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01327612
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) treatment 2 completed NCT05625412
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors treatment 1 recruiting NCT05954312
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01337310
Study of Tesetaxel in Japanese Patients With Solid Tumors treatment 1 unknown_status NCT00441610
An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor treatment 1 completed NCT03931681
A Study of OKI-179 in Patients With Solid Tumors treatment 1 completed NCT01296581
Safety Study of X-82 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05083481
A Study of ASP1570 Taken by Itself or With Pembrolizumab in Adults With Solid Tumors treatment 1 / 2 recruiting NCT01213381
Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors treatment 1 completed NCT04972981
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02799095
A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors treatment 1 / 2 completed NCT01055795
Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors treatment 1 completed NCT06178614
A Study of JNJ-87890387 for Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05905614
Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors treatment 1 / 2 completed NCT02442414
A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02561455
Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial treatment 1 / 2 completed NCT01005355
Study of IMC-1121B in Patients With Advanced Solid Tumors treatment 1 completed NCT02031055
Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors treatment 1 completed NCT05824455
A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors treatment 1 / 2 terminated NCT03588650
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02690350
An Open Study Assessing the Safety and Tolerability of U3-1784 No drug interventions treatment 1 terminated NCT02829723
A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors treatment 1 / 2 terminated NCT05125523
A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05017623
A Study to Evaluate YH003 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01106508
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors treatment 1 completed NCT00908908
A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors treatment 1 completed NCT06199908
AMT-562 in Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06012708
Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 No drug interventions treatment 1 recruiting NCT01098838
Safety and Efficacy of LCL161 in Patients With Solid Tumors treatment 1 completed NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) treatment 1 active_not_recruiting NCT03138538
M8891 First in Human in Solid Tumors No drug interventions treatment 1 terminated NCT06214143
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors treatment 1 / 2 recruiting NCT03317743
Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03799003
A Study of ASP1951 in Subjects With Advanced Solid Tumors treatment 1 terminated NCT03744403
A Study of CS1001 in Subjects With Advanced Solid Tumors treatment 1 completed NCT04126590
Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00520390
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) treatment 1 completed NCT05858164
A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors No drug interventions basic_science 1 recruiting NCT01215864
Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00069264
Study of E7389 in Patients With Advanced Solid Tumors treatment 1 completed NCT05804864
A Study of KM501 in Patients With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05768321
Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation No drug interventions treatment 1 recruiting NCT04999202
A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults treatment 1 active_not_recruiting NCT02936102
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. treatment 1 active_not_recruiting NCT00782002
Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy treatment 1 completed NCT05740202
A Trial of SHR-7367 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02225002
Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors treatment 1 completed NCT01529684
A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body other 1 completed NCT05599984
Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors treatment 1 recruiting NCT06039384
A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation treatment 1 active_not_recruiting NCT01220284
Satraplatin and Vinorelbine in Advanced Solid Tumors treatment 1 unknown_status NCT00726687
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors treatment 1 / 2 unknown_status NCT04890587
A Phase I Study of AL8326 in Advanced Solid Tumor No drug interventions treatment 1 unknown_status NCT00733187
Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869 basic_science 1 completed NCT04967833
Study on TIL for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT02205333
A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies treatment 1 / 2 terminated NCT01401933
Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors basic_science 1 completed NCT05470933
A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00725933
Administration of BIIB028 to Subjects With Solid Tumors No drug interventions treatment 1 completed NCT06417554
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT04172454
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors treatment 1 / 2 completed NCT03733951
KN046 in Subjects With Advanced Solid Tumors and Lymphoma treatment 1 completed NCT00513851
Phase 1 Study of OSI-930 in Cancer Patients treatment 1 completed NCT04047251
A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma treatment 1 recruiting NCT02994953
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12) treatment 1 terminated NCT00739453
A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®) treatment 1 completed NCT05234853
Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03945253
Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03787953
A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors No drug interventions Not Available Not Available unknown_status NCT02797977
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects treatment 1 / 2 completed NCT00858377
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT01231347
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas treatment 3 completed NCT02214147
Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function treatment 1 completed NCT02834247
A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors other 1 terminated NCT03654547
Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer treatment 1 active_not_recruiting NCT03089645
MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel. treatment 1 completed NCT03565445
A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors treatment 1 completed NCT06004245
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of RO7589831 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05830045
A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05240898
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors treatment 1 recruiting NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) treatment 1 completed NCT01128998
Sorafenib Plus S-1 in Advanced Solid Tumors treatment 1 completed NCT04393298
A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors treatment 1 / 2 completed NCT03713905
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors treatment 1 completed NCT03544905
Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 No drug interventions treatment 1 recruiting NCT00734305
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment treatment 1 completed NCT05646797
A Study of ASP2074 in Adults With Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00793897
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors treatment 1 completed NCT02316197
Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia treatment 1 completed NCT01910597
Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03292783
This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Tolerated Dose and/or Recommended Phase 2 Study Dose of ABL001 treatment 1 completed NCT06235983
A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03897283
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT03604783
Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors treatment 1 terminated NCT00726583
Phase I Trial of Oral PX-866 treatment 1 completed NCT01953783
Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB treatment 1 completed NCT03439761
An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma treatment 1 / 2 unknown_status NCT05387928
A Study of KL340399 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04325711
A Study of CSPCHA131 in Patients With Advanced Solid Tumor No drug interventions treatment 1 unknown_status NCT03861793
A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2) treatment 1 / 2 completed NCT04214093
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors No drug interventions treatment 1 terminated NCT03545971
A Study of IBI310 for the Treatment of Patients With Advanced Solid Tumors. treatment 1 completed NCT04052971
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation No drug interventions treatment 1 recruiting NCT00359671
Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001) treatment 1 terminated NCT01170871
Ixabepilone and Pemetrexed/Solid Tumors treatment 1 withdrawn NCT01897571
Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL treatment 1 / 2 completed NCT05105971
Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China No drug interventions treatment 1 active_not_recruiting NCT05942378
A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT01898078
Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT06311578
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors treatment 1 recruiting NCT03251378
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors, Colorectal, and Breast Cancer treatment 1 active_not_recruiting NCT03113188
CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors treatment 1 completed NCT01094288
A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen treatment 1 completed NCT06336707
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors treatment 1 recruiting NCT02462707
A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors treatment 1 withdrawn NCT00514007
Study of Continuous OSI-906 Dosing treatment 1 completed NCT03853109
AMG 404 in Patients With Advanced Solid Tumors treatment 1 completed NCT05272709
TT-702 in Patients With Advanced Solid Tumours. treatment 1 / 2 recruiting NCT05194709
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors treatment 0 unknown_status NCT02281409
Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors treatment 1 / 2 completed NCT06172309
A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02614456
Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors treatment 1 completed NCT00557856
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors treatment 1 completed NCT05172856
A Phase Ib Study of Primary Efficacy and Safety of IBI321 Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06400485
AMT-676 in Patients With Advanced Solid Tumors No drug interventions treatment 0 not_yet_recruiting NCT02261285
ONO-4538 Phase I Study in Patients With Solid Tumor treatment 1 completed NCT04601285
A Phase I Study of JS108 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05509985
A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS No drug interventions treatment 1 recruiting NCT05823285
A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients No drug interventions treatment 1 recruiting NCT00507585
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin treatment 1 completed NCT02965885
A Study of TAS-116 in Patients With Solid Tumors treatment 1 completed NCT05114915
A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT05868915
HV-101 for Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00520637
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) Not Available 1 completed NCT02940132
A Study of SC10914 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT02622932
Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients treatment 1 completed NCT03869632
First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors No drug interventions treatment 1 unknown_status NCT05949632
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT05731752
Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02367352
Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors treatment 1 terminated NCT06384352
A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01238952
Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer treatment 1 completed NCT01137552
A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT06480552
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT01469052
First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors treatment 1 completed NCT04943900
A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors treatment 1 active_not_recruiting NCT03319459
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors treatment 1 completed NCT03208959
A Trial of HTI-1090 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00949559
Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors treatment 1 completed NCT01928459
Phase 1b Trial of BGJ398/BYL719 in Solid Tumors treatment 1 completed NCT05114759
A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04074759
FPT155 in Patients With Advanced Solid Tumors treatment 1 completed NCT04471675
Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel treatment 1 unknown_status NCT04001075
Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 completed NCT04261075
IPH5201 as Monotherapy or in Combination With Durvalumab +/- Oleclumab in Subjects With Advanced Solid Tumors. treatment 1 completed NCT05109975
A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04747470
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors treatment 1 terminated NCT06082570
A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients No drug interventions treatment 1 / 2 not_yet_recruiting NCT03522142
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies treatment 1 active_not_recruiting NCT03864042
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors treatment 1 active_not_recruiting NCT00874042
Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT01521299
A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors treatment 1 withdrawn NCT03297606
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) treatment 2 recruiting NCT00708006
A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05976906
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03406949
MGD009/MGA012 Combination in Relapsed/Refractory Cancer treatment 1 completed NCT05233436
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors treatment 1 terminated NCT03179436
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001) treatment 1 / 2 completed NCT01161836
An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi) basic_science 1 completed NCT06376136
A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors No drug interventions treatment 1 / 2 recruiting NCT06183736
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency No drug interventions treatment 2 not_yet_recruiting NCT02516813
Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy treatment 1 completed NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05008913
Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib other 1 terminated NCT06370013
Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors Not Available Not Available available NCT05494918
First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors No drug interventions treatment 1 recruiting NCT00605618
Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors treatment 1 / 2 completed NCT01847118
A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 unknown_status NCT02179918
A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036) treatment 1 completed NCT04068519
Study Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1 (Programmed Death-1) Monoclonal Antibody treatment 1 / 2 completed NCT00861419
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. treatment 1 completed NCT05609019
A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04826341
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors treatment 1 / 2 recruiting NCT03310541
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations treatment 1 completed NCT01331941
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function treatment 1 completed NCT01992341
AMG 386 Drug-Drug Interaction Study With Paclitaxel treatment 1 completed NCT06235541
A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT00785941
A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available Not Available 1 completed NCT01190241
Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study treatment Not Available terminated NCT06445517
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma No drug interventions treatment 1 recruiting NCT02243917
A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors treatment 1 terminated NCT05620017
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection No drug interventions treatment 1 not_yet_recruiting NCT05818917
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 enrolling_by_invitation NCT02301117
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment treatment 1 completed NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers treatment 1 completed NCT05731934
The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04272034
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00632424
Phase 1 Trial of Oral Ixabepilone treatment 1 terminated NCT05252416
(VELA) Study of BLU-222 in Advanced Solid Tumors treatment 1 / 2 recruiting NCT01063816
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors treatment 1 completed NCT05914116
A Study of DB-1311 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04659096
A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors No drug interventions treatment 1 completed NCT00116896
Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors treatment 1 completed NCT05605496
NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies No drug interventions treatment 2 recruiting NCT00974896
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors treatment 1 completed NCT04735796
Study of LM-102 in Subjects in Advanced Tumors No drug interventions treatment 1 terminated NCT05564858
A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors No drug interventions treatment 1 recruiting NCT03361358
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma No drug interventions Not Available Not Available completed NCT02565758
ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05164458
Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies treatment 1 recruiting NCT00410358
A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor. treatment 1 completed NCT01512758
A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT00487058
A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors treatment 1 completed NCT00462358
A Study of ARRY-520 in Patients With Advanced Cancer treatment 1 completed NCT00792558
Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers treatment 1 withdrawn NCT02693535
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer treatment 2 recruiting NCT04626635
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers treatment 1 / 2 recruiting NCT01706835
Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors treatment 1 completed NCT01284335
A Safety Study in Participants With Advanced Solid Tumors treatment 1 terminated NCT05367635
A Study of SKB315 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00592163
Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas treatment 1 unknown_status NCT05393063
A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00955786
Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT00947739
Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma No drug interventions treatment 1 completed NCT01238939
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer treatment 1 completed NCT05086822
A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors treatment 1 completed NCT01912222
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction treatment 1 completed NCT03320525
Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN) No drug interventions treatment 1 terminated NCT00750425
Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours treatment 1 completed NCT01306630
A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors treatment 1 completed NCT03910530
A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors treatment 1 completed NCT05086848
A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors treatment 1 completed NCT01471548
Phase I Dose Escalating Study of TKI258 treatment 1 completed NCT02875548
A Study to Assess the Long-term Safety of Tazemetostat treatment 1 / 2 enrolling_by_invitation NCT01255657
A Study of ABT-806 in Subjects With Advanced Solid Tumor Types treatment 1 completed NCT06547957
A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02900157
Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors treatment 1 completed NCT01497626
Lapatinib and Bortezomib in Patients With Advanced Malignancies treatment 1 terminated NCT03529526
Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors treatment 1 unknown_status NCT01386866
Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors diagnostic 1 completed NCT02583165
A Study in Adult Subjects With Select Advanced Solid Tumors No drug interventions treatment 1 completed NCT06532565
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors treatment 1 recruiting NCT00747474
Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors treatment 1 completed NCT04449874
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation treatment 1 recruiting NCT00782574
Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients treatment 1 completed NCT06096974
Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS No drug interventions treatment 1 not_yet_recruiting NCT01946074
A Study of ABT-165 in Subjects With Solid Tumors treatment 1 completed NCT04856774
Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors treatment 1 / 2 completed NCT02261220
A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors treatment 1 completed NCT01723020
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma treatment 1 completed NCT05867420
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. No drug interventions treatment 1 recruiting NCT00139620
A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function treatment 1 completed NCT05773820
A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 enrolling_by_invitation NCT00426582
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT05862831
Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06428331
A Study of SKB518 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06047431
A Study of QL1706H in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT03256331
Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients No drug interventions treatment 1 terminated NCT02637531
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 treatment 1 unknown_status NCT06314373
A Study for HSK39775 in Participants With Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05879627
To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors treatment 1 recruiting NCT03854227
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors treatment 1 terminated NCT00558727
Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma No drug interventions treatment 1 terminated NCT01016327
Study of NMS-1116354 in Solid Tumors No drug interventions treatment 1 terminated NCT05914376
Safety of Recombinant Human IL-21 Oncolytic Vaccinia Virus Injection（hV01) in Advanced Tumors treatment 1 recruiting NCT06368960
BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04672460
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors treatment 1 completed NCT04446260
A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT04911894
A Study of Dose Escalation of IBI321 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03641794
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers No drug interventions treatment 1 unknown_status NCT02318394
A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT05593094
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors treatment 1 recruiting NCT00962091
Study of MLN8237 in Participants With Advanced Solid Tumors treatment 1 completed NCT05116891
A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors treatment 1 / 2 completed NCT06076291
An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01987362
A Two Part Study of RO6870810. Dose-Escalation Study in Participants With Advanced Solid Tumors and Expansion Study in Participants With Selected Malignancies treatment 1 completed NCT01693562
A Phase 1/2 Study to Evaluate MEDI4736 treatment 1 / 2 completed NCT02454062
A Trial of TAS-114 in Combination With S-1 No drug interventions treatment 1 completed NCT05389462
A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors treatment 1 recruiting NCT05275062
Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma No drug interventions treatment 0 unknown_status NCT00891280
Dose-escalation Study of Oral CX-4945 treatment 1 unknown_status NCT01056029
Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors treatment 1 completed NCT00207129
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies treatment 1 completed NCT02318329
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors treatment 1 completed NCT04699929
A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04991129
The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer No drug interventions treatment 1 recruiting NCT01781429
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies treatment 1 / 2 completed NCT02721589
A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects treatment 1 completed NCT06443489
A Trial of SHR-4849 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06439589
Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04623892
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00955292
Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas treatment 1 terminated NCT02253992
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma treatment 1 / 2 terminated NCT04868344
A Study of MRG003 in Patients With Advanced Solid Tumors treatment 1 completed NCT06555744
A Study of ZW191 in Participants With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05537740
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors treatment 1 recruiting NCT04144140
Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 No drug interventions treatment 1 terminated NCT01980667
Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors treatment 1 completed NCT04830501
Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT01299701
A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors treatment 1 terminated NCT06026501
A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 not_yet_recruiting NCT06238401
Study of ACR246 in Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT00999401
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors treatment 1 completed NCT06364501
Phase 1 Trial of KH801 No drug interventions treatment 1 not_yet_recruiting NCT04006301
First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation No drug interventions treatment 1 completed NCT03954704
Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01444404
A Study of AMG 820 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03715504
Study of TP-3654 in Patients With Advanced Solid Tumors treatment 1 completed NCT02987504
Study of Samalizumab in Patients With Advanced Cancer treatment 1 terminated NCT04335604
A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors treatment 1 completed NCT01491204
Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer treatment 1 completed NCT03034304
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors treatment 1 recruiting NCT02301104
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment treatment 1 completed NCT01999972
A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors treatment 1 completed NCT04169672
Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors treatment 2 completed NCT03219268
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms treatment 1 completed NCT01007968
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function other 1 completed NCT05277168
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS treatment 1 / 2 recruiting NCT02644369
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors treatment 2 active_not_recruiting NCT01139346
Study of Oral Darinaparsin in Patients With Advanced Solid Tumors treatment 1 completed NCT05338346
A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies No drug interventions treatment 1 terminated NCT00099346
MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) No drug interventions treatment 1 terminated NCT01210846
A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors Not Available 1 completed NCT01938612
A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours treatment 1 completed NCT06208410
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors treatment 1 / 2 recruiting NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors treatment 1 completed NCT02259010
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma basic_science 1 completed NCT04911881
A Study of the Safety and Tolerability of IBI321 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00794781
A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors treatment 1 completed NCT02844881
Study of Apatinib and MASCT in Patients With Advanced Solid Tumors treatment 1 / 2 unknown_status NCT03525795
ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors treatment 1 completed NCT06394414
A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors treatment 1 recruiting NCT03348514
Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT06341114
A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06544655
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT03893955
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT05430555
A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors No drug interventions treatment 1 / 2 terminated NCT06239155
A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02110355
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma treatment 1 completed NCT06224855
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies No drug interventions treatment 1 not_yet_recruiting NCT06474455
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT03440450
A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer treatment 1 recruiting NCT05394350
A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) treatment 1 / 2 terminated NCT03435250
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss treatment 1 terminated NCT03901950
Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of XNW7201 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04856150
A Study of Q-1802 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06381050
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03065023
Study of Intralesional Administration of MK-4621 (RGT100) in Adult Participants With Advanced or Recurrent Tumors (MK-4621-001/RGT100-001) No drug interventions treatment 1 / 2 terminated NCT05951608
A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT06556108
ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors treatment 1 / 2 recruiting NCT06188208
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors treatment 1 recruiting NCT01636908
Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies. diagnostic Not Available completed NCT00529438
RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies treatment 1 completed NCT03739138
Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002) treatment 1 terminated NCT03134638
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors treatment 1 terminated NCT00785538
A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available treatment 1 completed NCT05880043
GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies No drug interventions treatment 1 / 2 recruiting NCT04699643
FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 / 2 unknown_status NCT03666143
A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 completed NCT01472003
An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types diagnostic 1 completed NCT04577703
First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors treatment 1 completed NCT05171790
A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors treatment 1 active_not_recruiting NCT01009190
A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens treatment 1 completed NCT00207090
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer treatment 1 completed NCT05469490
Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors treatment 1 withdrawn NCT05800964
Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors No drug interventions basic_science 1 recruiting NCT03514121
FPA150 in Patients With Advanced Solid Tumors treatment 0 completed NCT01773421
An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subjects With Unresectable Solid Tumors treatment 1 completed NCT01012102
EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors treatment 1 completed NCT05614102
A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors treatment 1 recruiting NCT00879684
Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00813384
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors treatment 1 completed NCT03895684
Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors treatment 1 completed NCT03322384
UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma treatment 1 / 2 completed NCT00682279
A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors treatment 1 withdrawn NCT01610479
A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04408079
A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets No drug interventions treatment 1 unknown_status NCT04449562
A Phase 1 Trial of the p97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 recruiting NCT03972436
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. No drug interventions treatment 1 / 2 not_yet_recruiting NCT05109650
Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients No drug interventions treatment 1 terminated NCT05461287
Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01453387
MSC2015103B in Solid Tumors No drug interventions treatment 1 terminated NCT04799054
A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT06130254
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers treatment 1 recruiting NCT05867251
Study of AVZO-021 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06367751
Implementation of Liquid Biopsies During Routine Clinical Care in Patients With Advanced Malignancies (LIQPLAT) No drug interventions other Not Available recruiting NCT05639751
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation treatment 1 recruiting NCT02076451
Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT06514651
MAQ-001 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04977453
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors treatment 1 / 2 recruiting NCT05199753
Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT05518253
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05208177
A Study of SHR-1802 in Patients With Advanced Solid Tumor treatment 2 recruiting NCT05505877
Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04374877
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors treatment 1 recruiting NCT00503477
A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan treatment 1 completed NCT05275777
A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer treatment 1 / 2 active_not_recruiting NCT06094777
A Study of HY-0102 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05525247
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination treatment 1 / 2 recruiting NCT05790447
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors treatment 2 recruiting NCT04871347
The Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor No drug interventions treatment 1 unknown_status NCT05649345
TR64 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05518045
Study of LM-108 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours treatment 1 / 2 recruiting NCT05043298
A Phase Ia/Ib Clinical Trial of IBI360 Monotherapy or in Combination With Sintilimab and (or) Chemotherapy in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 unknown_status NCT05429398
A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor treatment 1 unknown_status NCT01832298
Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor No drug interventions treatment 1 completed NCT04761198
A Study of Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors. basic_science 1 / 2 completed NCT03903705
: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors treatment 1 / 2 recruiting NCT06074705
A Study of DS-1471a In Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00501605
Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases treatment 1 completed NCT04237805
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients No drug interventions treatment 1 / 2 recruiting NCT00742105
Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan No drug interventions treatment 1 terminated NCT03874897
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors. treatment 1 completed NCT05169697
A Study to Assess YH002 in Combination With YH001 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04896697
Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors treatment 1 / 2 recruiting NCT06457997
A Study of PHN-010 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT06432283
A Machine Learning-based Estimated Survival Model No drug interventions Not Available Not Available active_not_recruiting NCT06334783
TIL for Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT05071183
A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors treatment 1 / 2 terminated NCT05491083
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer treatment 1 / 2 recruiting NCT06120283
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors treatment 1 recruiting NCT04478461
Safety, Tolerability, and Pharmacokinetics of MW11 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04375228
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) treatment 2 recruiting NCT05377528
Study of AGEN1571 in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT02862028
PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach) No drug interventions treatment 1 / 2 unknown_status NCT05785728
A Study of DB-1202 Monotherapy in Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT05584111
Oral Administration of STC-15 in Subjects With Advanced Malignancies No drug interventions treatment 1 active_not_recruiting NCT05107011
Phase I/II Clinical Trial of LBL-015 for Injection No drug interventions treatment 1 / 2 recruiting NCT05246111
Berzosertib Human Mass Balance Study (DDRiver Solid Tumors 208) treatment 1 completed NCT04060511
A Study of HS-10342 in Patients With Advanced Solid Tumor No drug interventions treatment 1 completed NCT06006793
A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation No drug interventions treatment 1 recruiting NCT04886271
Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors No drug interventions treatment 2 unknown_status NCT04282278
Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor treatment 2 unknown_status NCT04579978
Tumor Immunotherapy and Microbiome Analysis No drug interventions Not Available Not Available recruiting NCT05378178
A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01588678
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT04215978
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT04735978
Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours treatment 1 active_not_recruiting NCT04936178
A Study of NB003 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 2 recruiting NCT06446388
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors treatment 2 not_yet_recruiting NCT05320588
A Study in Patients With Advanced Cancers treatment 1 / 2 recruiting NCT04284488
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors treatment 1 / 2 recruiting NCT03179007
CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT04805307
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 treatment 1 recruiting NCT06383507
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05706207
A Study of HB0030 Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05780307
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05644509
Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor No drug interventions treatment 1 not_yet_recruiting NCT05522309
FGFR Inhibitor ET0111 Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05584709
Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06241456
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors treatment 1 recruiting NCT04855656
Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06225856
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies No drug interventions treatment 1 recruiting NCT05751356
TR128 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06543056
A Study of ES014 in Subjects With Advanced Solid Tumors No drug interventions treatment 2 not_yet_recruiting NCT06484985
Study of AXT-1003 in Subjects With Advanced Malignant Tumors. No drug interventions treatment 1 not_yet_recruiting NCT04775485
A Study to Evaluate DAY101 in Pediatric and Young Adult Patients With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors treatment 2 recruiting NCT06244485
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors treatment 1 recruiting NCT05901285
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05515185
B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors treatment 0 not_yet_recruiting NCT05944185
Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT04471415
Study to Investigate DRP-104 in Adults With Advanced Solid Tumors treatment 1 / 2 terminated NCT04186637
An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies No drug interventions treatment 1 terminated NCT03163732
Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors. No drug interventions diagnostic Not Available completed NCT05098132
Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors treatment 1 recruiting NCT05768932
BAL0891 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06054932
Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors No drug interventions treatment 1 recruiting NCT05888532
64Cu-GRIP B in Patients With Advanced Malignancies diagnostic 1 / 2 recruiting NCT05752552
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours No drug interventions treatment 1 recruiting NCT04062552
Learning Collaborative Vs Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer No drug interventions health_services_research Not Available enrolling_by_invitation NCT04322552
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects treatment 1 completed NCT05990452
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05058352
A Study of HS269 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05544552
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations No drug interventions treatment 1 / 2 recruiting NCT04156100
A Study in Subjects With Advanced Solid Tumors treatment 1 terminated NCT05681000
Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06428500
QTX3046 in Patients With KRAS G12D Mutations treatment 1 recruiting NCT05508100
Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors treatment 1 completed NCT05245500
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion treatment 1 / 2 recruiting NCT04865159
Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies basic_science 1 terminated NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT05525559
SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04691375
A Study of PY314 in Subjects With Advanced Solid Tumors treatment 1 terminated NCT04294875
Phase I, FIH, MTD for MPT0B640, Multi-centre, Open-label, Subject With Locally Advanced or Metastatic Solid Malignancies treatment 0 withdrawn NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03767075
A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) treatment 2 recruiting NCT05002270
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation treatment 1 / 2 recruiting NCT05341570
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BPI-21668 No drug interventions treatment 1 recruiting NCT05143970
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03950570
ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer treatment 1 / 2 active_not_recruiting NCT06332170
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05434299
A Study of TFX05-01 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04441099
NBE-002 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT05898399
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients treatment 1 / 2 recruiting NCT05072106
Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT04089449
A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas No drug interventions treatment 1 completed NCT05642949
Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT05414136
Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 No drug interventions treatment 1 active_not_recruiting NCT05809336
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors treatment 2 / 3 completed NCT03975036
Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody treatment 2 / 3 unknown_status NCT06403436
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01237236
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. treatment 1 completed NCT02870036
Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT05382936
Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid Tumors No drug interventions treatment 1 completed NCT00509613
Phase 1 Study With Sorafenib and Sirolimus Not Available 1 completed NCT04795713
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 No drug interventions treatment 1 recruiting NCT04890613
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation treatment 1 recruiting NCT03615313
PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT05055518
APL-102 Capsule in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT06365918
Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis No drug interventions treatment 1 not_yet_recruiting NCT04282018
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab treatment 1 / 2 active_not_recruiting NCT05892718
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors No drug interventions treatment 1 recruiting NCT05228119
A Study of Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05020119
Neoantigen-expanded Autologous Immune Cell Therapy No drug interventions treatment 1 unknown_status NCT06173219
Safety and Efficacy of Radiotherapy Combined With Immunotherapy for Advanced Malignant Tumors. No drug interventions treatment 1 / 2 recruiting NCT06277219
A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1) No drug interventions treatment 1 / 2 recruiting NCT03172819
Special Combination of OBP-301 and Pembrolizumab treatment 1 completed NCT04866641
Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05051241
A Study of GFH018 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04418141
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1 No drug interventions treatment 1 completed NCT05785741
A Study of DB-1310 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04762641
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects With Any Progressive Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06037317
A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors treatment 1 recruiting NCT05462717
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06132217
A Study of Simmitinib Plus SG001 in Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT04892017
A Phase 1/2 Study of DCC-3116 in Patients With RAS/MAPK Pathway Mutant Solid Tumors treatment 1 / 2 recruiting NCT05638334
Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours No drug interventions treatment 1 terminated NCT04851834
NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma treatment 1 / 2 terminated NCT04497116
Study of RP-3500, Camonsertib, in Advanced Solid Tumors treatment 1 / 2 recruiting NCT05829616
A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05001516
Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors treatment 1 completed NCT06484816
TGRX-1942 Chinese Phase I for Advanced Solid Tumor and/or Relapsed/Refractory Hematologic Malignancies No drug interventions treatment 1 not_yet_recruiting NCT04042116
A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor treatment 1 / 2 suspended NCT04785196
APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors treatment 1 / 2 recruiting NCT06038396
A Study of RC118 Plus Toripalimab in Patients With Locally Advanced Unresectable or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT05076396
PM14 Administered Intravenously to Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05120596
First in Human Study of T3P-Y058-739 (T3P) treatment 1 / 2 recruiting NCT05293496
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT04472858
A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors treatment 1 recruiting NCT05170958
A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT05381935
A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 withdrawn NCT04440735
A Study of DSP107 Alone and in Combination With Atezolizumab for Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05649163
Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy Not Available Not Available not_yet_recruiting NCT06287463
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway No drug interventions treatment 1 / 2 recruiting NCT04151186
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors No drug interventions treatment Not Available unknown_status NCT05873686
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers No drug interventions treatment 1 recruiting NCT04914286
A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT05478486
Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours No drug interventions basic_science 1 unknown_status NCT05621486
A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06084286
Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients With CLDN18.2-positive Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06197139
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04505839
First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors No drug interventions treatment 1 completed NCT05879822
A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive No drug interventions treatment 2 active_not_recruiting NCT05155722
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04998422
A Study of HG381 Administered to Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05621525
Phase I Study of the BBP-398 in Patients With Advance Solid Tumors No drug interventions treatment 1 terminated NCT05378425
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab treatment 1 recruiting NCT05895825
A Study of EOC237 in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT01469130
A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors treatment 1 completed NCT04430348
PTX-35 in Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05916248
Personalized Tumor Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01106248
QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors treatment 1 completed NCT06249048
Study of IT STX-001 in Patients With Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab treatment 1 / 2 recruiting NCT05569057
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma No drug interventions treatment 1 recruiting NCT05955157
Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma treatment 2 / 3 recruiting NCT05888857
MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. treatment 2 not_yet_recruiting NCT06247657
A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT04434326
The Absorption, Metabolism and Excretion of [14C]CM082 in Human No drug interventions treatment 1 completed NCT05443126
A Study of EP0031 in Patients With Advanced RET-altered Malignancies No drug interventions treatment 1 / 2 recruiting NCT05267626
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT05009966
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor No drug interventions treatment 1 unknown_status NCT06126666
A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04093466
A Phase 1 Study of CX1003 (Kanitinib) in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05258266
A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT06540066
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors treatment 1 not_yet_recruiting NCT06008366
A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors treatment 1 / 2 recruiting NCT06090266
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT04510766
Tumor Molecular Profiling in Early Phase Clinical Trials No drug interventions Not Available Not Available recruiting NCT05156866
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer No drug interventions treatment 1 recruiting NCT04912466
IBI322 Monotherapy or Combination Therapy in Subjects With Advanced Malignant Tumors. No drug interventions treatment 1 completed NCT06226766
JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors No drug interventions treatment 1 / 2 recruiting NCT05684965
XTX301 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04719065
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor treatment 1 unknown_status NCT05101265
Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment treatment 1 recruiting NCT03188965
First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas treatment 1 completed NCT06466265
Study of DNP002 in Patients With Solid Tumors No drug interventions treatment 1 recruiting NCT05222165
Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations treatment 1 / 2 withdrawn NCT03929965
Anlotinib in Advanced Solid Tumors With FGFR Alteration treatment Not Available unknown_status NCT04986865
A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas treatment 1 recruiting NCT06260774
Study of TTX-MC138 in Subjects With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06143774
Study of TRX-920 for Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04622774
First-in-Human Study of IMGC936 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 completed NCT06422520
A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 recruiting NCT05990920
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy No drug interventions treatment 1 active_not_recruiting NCT04973020
A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers basic_science 1 completed NCT05007782
Study of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors treatment 1 recruiting NCT05291182
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05687682
Safety of AM-928 Infusion in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06007482
A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03969082
Evaluation of Bibliotherapy by Students and Patients With Cancer No drug interventions supportive_care Not Available completed NCT04165031
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation treatment 1 / 2 terminated NCT05908773
A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors other 0 completed NCT06328673
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors treatment 1 recruiting NCT04849273
A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC treatment 1 terminated NCT03993873
Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET treatment 1 / 2 active_not_recruiting NCT04906473
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00262327
Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor No drug interventions treatment 1 unknown_status NCT05631327
A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT05117476
A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors treatment 1 recruiting NCT04083976
A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations treatment 2 active_not_recruiting NCT01392976
Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors treatment 1 completed NCT06047860
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer treatment 2 recruiting NCT06577194
A Single-Center, Single-Arm Study of Neoadjuvant Short-Course Radiotherapy Concurrent With IL-2 Followed by Sequential Immunotherapy With CAPOX Combined With PD-1 Antibody and IL-2 for Locally Advanced Rectal Cancer treatment 2 not_yet_recruiting NCT03154294
Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors treatment 1 completed NCT05166694
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions No drug interventions treatment Not Available recruiting NCT04887194
PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates treatment 1 completed NCT06163391
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer No drug interventions treatment 1 recruiting NCT04161391
Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations No drug interventions treatment 1 / 2 terminated NCT04713891
A Study of KF-0210 in Advanced Solid Tumors Patients treatment 1 unknown_status NCT05725291
AMT-116 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05076591
IMM2902, a HER2/SIRPα Bispecific mAb-Trap Antibody-receptor Fusion Protein, in Patients With HER2-expressing Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04638491
Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients treatment 1 completed NCT04561362
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies treatment 1 / 2 recruiting NCT06302062
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors treatment 1 recruiting NCT05263180
A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors. No drug interventions treatment 1 recruiting NCT01762280
A Phase I Study of Famitinib Malate in Patients With Solid Tumor No drug interventions treatment 1 completed NCT06001580
A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05650580
TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04423380
A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04457180
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects treatment 1 completed NCT06426680
A Study of the ILB-3101 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05982080
A Study to Investigate FP002 in Subjects With Advanced Malignancies No drug interventions treatment 1 recruiting NCT06257680
A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04049929
A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04659629
NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer treatment 1 active_not_recruiting NCT04989829
Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects basic_science 1 completed NCT02157792
M6620 First in Human Study treatment 1 completed NCT05602792
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05757492
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT02979392
Phase I Study of TENPA in Advanced Solid Cancer treatment 1 terminated NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05306444
CLN-418 Study on Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03499444
A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor treatment 1 completed NCT06035744
CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04328740
Phase 1 Study of Oral TP-1454 No drug interventions treatment 1 active_not_recruiting NCT05146440
Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination With Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT06005740
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer No drug interventions treatment 1 recruiting NCT05159440
First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer No drug interventions treatment 1 active_not_recruiting NCT04464967
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers treatment 1 / 2 withdrawn NCT05315167
A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05872867
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) treatment 1 recruiting NCT00502567
A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors treatment 1 completed NCT06048367
Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor treatment 1 recruiting NCT06363201
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours No drug interventions supportive_care Not Available not_yet_recruiting NCT03758001
First in Human Study of IBI101 in Chinese Subjects With Advanced Solid Tumors treatment 1 completed NCT04088604
Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors treatment 1 completed NCT05094804
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT05122572
RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05578872
A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). treatment 1 / 2 recruiting NCT05226468
An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia No drug interventions treatment 1 active_not_recruiting NCT04797468
A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor No drug interventions treatment 1 withdrawn NCT01769768
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients treatment 1 completed NCT05875168
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05933668
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor No drug interventions treatment 1 not_yet_recruiting NCT05598268
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. treatment 1 / 2 recruiting NCT05886868
Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06490068
Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy treatment 2 recruiting NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT03217669
Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy treatment 1 active_not_recruiting NCT04097769
The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT06240546
First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors. No drug interventions treatment 1 recruiting NCT05501912
A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06251310
SW-682 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05082610
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab treatment 1 recruiting NCT05065710
A Study of ZL-1211 in Patients With Advanced Solid Tumor No drug interventions treatment 1 completed NCT04827810
A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer No drug interventions treatment 1 suspended NCT06404281
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05831995
Safety and Effectiveness of ABM-168 in Adults With Advanced Solid Tumors. No drug interventions treatment 1 recruiting NCT03889795
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors treatment 1 recruiting NCT04324814
A Trial of SHR-1701 in Subjects With Advanced Solid Tumors treatment 1 completed NCT04144855
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection No drug interventions treatment 1 unknown_status NCT06488950
A Study on TIL for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT05205850
A Study of RC118 in Patients With Locally Advanced Unresectable or Metastatic Malignant Solid Tumors treatment 1 / 2 recruiting NCT05701150
AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT No drug interventions Not Available Not Available recruiting NCT05147350
Study of RP-6306 With FOLFIRI in Advanced Solid Tumors treatment 1 active_not_recruiting NCT05417750
A Phase I Study on Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) for the Treatment of Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT05038150
Study of SGN1 in Patients With Advanced Solid Tumor treatment 1 / 2 recruiting NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) treatment 1 / 2 recruiting NCT06144723
Study of HS-20105 for Injection in Patients With Advanced Solid Tumors. No drug interventions treatment 1 / 2 not_yet_recruiting NCT05142423
A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06372223
A Food Effect Study of SPH5030 Tablets. No drug interventions treatment 1 completed NCT05761223
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 treatment 1 / 2 recruiting NCT06266923
A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors. No drug interventions treatment 0 completed NCT05983523
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04687423
Study of FCN-011 in Patients With Advanced Solid Tumor（Phase I）and NTRK Fusion Positive Advanced Solid Tumor （Phase II） No drug interventions treatment 1 unknown_status NCT06223308
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04268108
L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy Not Available Not Available unknown_status NCT06220838
Study SC-101 in Subjects With Advanced Malignancies No drug interventions treatment 1 recruiting NCT01673438
Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors treatment 1 completed NCT05635643
Study of CHS-114 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT01283503
A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors treatment 1 completed NCT04488003
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations treatment 2 terminated NCT06410703
CAN1012 Combined With PD-1 in Patients With Solid Tumors treatment 1 / 2 not_yet_recruiting NCT05828303
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT03182803
CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT05329103
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05161390
Study of LM-302 in Patients With Advance Solid Tumors treatment 1 / 2 active_not_recruiting NCT01755390
A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors treatment 1 completed NCT05468190
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T No drug interventions treatment 1 recruiting NCT05188664
Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors treatment 1 recruiting NCT05075564
A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05877664
Study of ZG0895.HCl in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06264921
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05417321
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05547321
Efficacy and Safety Study of OMTX705, Monotherapy and Pembrolizumab-combined, in Subjects With Advanced Solid Tumors. other 1 recruiting NCT05978102
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05346484
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors treatment 1 recruiting NCT04878484
Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 withdrawn NCT04999384
First in Human, Dose Escalation Study of AN4005 No drug interventions treatment 1 recruiting NCT05700084
Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04609579
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma treatment 1 terminated NCT06008379
A Study of 7MW3711 in Subjects With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04058587
A Phase I Trial of Simmitinib in Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04912687
Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients No drug interventions screening Not Available recruiting NCT04471987
Safety and Early Signs of Efficacy of IL12-L19L19. No drug interventions treatment 1 recruiting NCT06577987
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT05119933
A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation No drug interventions treatment 1 / 2 unknown_status NCT04947033
A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05126433
Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors (EMERGE-201) treatment 2 completed NCT05148533
A Study of Single Drug TJ011133 and Toripalimab Combine Treatment for Advanced Solid Tumor No drug interventions treatment 1 / 2 terminated NCT04843033
A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05765851
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors treatment 1 recruiting NCT04592653
Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3) treatment 1 / 2 active_not_recruiting NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours treatment 1 / 2 recruiting NCT05253053
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04891653
A Phase I Study of BR790 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04859777
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors treatment 1 unknown_status NCT01378377
Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus treatment 1 terminated NCT05821777
A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05794477
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06211647
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05420545
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05103345
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor treatment 1 / 2 recruiting NCT05008445
Study of LM-102 in Patients With Advance Solid Tumors No drug interventions treatment 1 / 2 terminated NCT05087745
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT04608045
Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03493945
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) treatment 1 / 2 active_not_recruiting NCT03239145
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor treatment 1 active_not_recruiting NCT06560645
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation No drug interventions treatment 1 not_yet_recruiting NCT05935098
A Study of BGB-A3055, Alone and in Combination With Tislelizumab in Participants With Selected Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT04336098
Study of SRF617 in Patients With Advanced Solid Tumors treatment 1 completed NCT04811898
A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment No drug interventions treatment 1 completed NCT05751798
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 / 2 recruiting NCT06525298
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors treatment 1 / 2 recruiting NCT02735798
64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets treatment 0 withdrawn NCT04740398
A Study of CBP-1008 in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT05363605
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours treatment 1 / 2 terminated NCT05173805
Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation No drug interventions treatment 1 / 2 enrolling_by_invitation NCT06404905
Clinical Trial of BT02 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04655183
Study of M4344 in Combination With Niraparib treatment 1 / 2 withdrawn NCT00861783
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma treatment 1 completed NCT05103683
First in Human Study of TORL-1-23 in Participants With Advanced Cancer No drug interventions treatment 1 recruiting NCT04920383
ALPN-202 With PD-1 Inhibition in Advanced Malignancies treatment 1 terminated NCT04135261
A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05202561
A Study of RNA Tumor Vaccine in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05661461
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment treatment 1 recruiting NCT04190628
Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors treatment 1 terminated NCT04675528
Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study treatment 1 completed NCT01546428
A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors treatment 1 completed NCT05014828
To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Patients With Selected Solid Tumors treatment 2 completed NCT06139211
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT05798611
Study of ART0380 in Patients With Biologically Selected Solid Tumors No drug interventions treatment 2 recruiting NCT06304571
A Study of HC006 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01455571
Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors treatment 1 completed NCT05367778
Phase 1/2 Study of HS-10370 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02644278
First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy No drug interventions treatment 1 completed NCT06408688
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors No drug interventions treatment 4 not_yet_recruiting NCT05178888
Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16) treatment 1 active_not_recruiting NCT05902988
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT05226507
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer No drug interventions treatment 1 recruiting NCT06081907
The Efficacy and Safety of IBI363 in Solid Tumors treatment 1 / 2 recruiting NCT03374007
Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma treatment 1 unknown_status NCT05756907
Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer No drug interventions treatment 1 / 2 recruiting NCT06143007
A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05276609
ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05081609
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or Chemotherapy or TransCon TLR7/8 Agonist in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 recruiting NCT05259709
A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab treatment 1 recruiting NCT05101109
Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT03272256
Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma treatment 1 completed NCT06198556
Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects treatment 1 completed NCT05805956
IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 No drug interventions treatment 1 / 2 recruiting NCT04357756
A Study to Assess YH001 in Combination With Toripalimab Injection in Subjects With Advanced Solid Tumors treatment 1 completed NCT06223256
A Study of NBL-028 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04649385
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors treatment 1 recruiting NCT06561685
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05950815
A Study of PM1015 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05764915
A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05645315
Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06413615
A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors No drug interventions treatment 2 not_yet_recruiting NCT04390737
Evaluate the Safety and Clinical Activity of HH2853 No drug interventions treatment 1 / 2 recruiting NCT06147037
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT05463432
A Study of HR19024 in Subjects With Advanced Solid Tumor No drug interventions treatment 1 unknown_status NCT03457532
A Phase I Study of SCC244 treatment 1 unknown_status NCT06533332
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05306132
Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 No drug interventions treatment 1 recruiting NCT05765032
Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06560632
Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT06334432
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05584800
Study of ZGGS18 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05159700
A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06078800
A Study of YL-17231 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05279300
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 recruiting NCT04689100
Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor treatment 1 unknown_status NCT02836600
A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors treatment 1 completed NCT05474859
Subjects With Advanced or Metastatic Solid Tumor Malignancies No drug interventions treatment 1 not_yet_recruiting NCT06533059
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors No drug interventions treatment 1 recruiting NCT06352359
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04278859
Safety, Tolerability and Pharmacokinetics of a Recombinant Humanized mAb Specific to B-and T-Lymphocyte Attenuator (BTLA) for Injection in Subjects With Advanced Malignancies treatment 1 unknown_status NCT05594875
A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT06078670
PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT05487170
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) No drug interventions treatment 1 / 2 recruiting NCT05580770
Mirdametinib + BGB-3245 in Advanced Solid Tumors treatment 1 / 2 recruiting NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT06115642
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05109442
Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers treatment 1 / 2 recruiting NCT03953742
Study of CPI-200 in Patients With Advanced Tumors No drug interventions treatment 1 completed NCT05344742
A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT06233942
Study of BG-C9074 as Monotherapy and in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 recruiting NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05097599
Strata PATH™ (Precision Indications for Approved Therapies) treatment 2 active_not_recruiting NCT06266299
A Study of KK2269 in Adult Participants With Solid Tumors treatment 1 recruiting NCT02553499
Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001) treatment 1 terminated NCT06219499
Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841 No drug interventions other 1 withdrawn NCT05837299
A Study of IMC008 for Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05924906
A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06509906
M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) treatment 1 not_yet_recruiting NCT04322006
A Phase I/II Study of TJ004309 for Advanced Solid Tumor treatment 1 / 2 active_not_recruiting NCT06373406
A Study of MHB036C for Advanced Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT05102006
Phase Ib/II Clinical Study of LBL-007 in Treatment of Advanced Malignant Tumors treatment 1 / 2 recruiting NCT05737706
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation No drug interventions treatment 1 / 2 recruiting NCT05099549
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers No drug interventions treatment 1 / 2 terminated NCT06075849
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent No drug interventions treatment 1 recruiting NCT06139536
Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients No drug interventions treatment 1 recruiting NCT06019013
A Study of QLF3108 in Participants With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT04705818
Combining Epigenetic And Immune Therapy to Beat Cancer. treatment 2 recruiting NCT05394818
The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06090318
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss treatment 1 / 2 withdrawn NCT05498519
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT05909241
A Study of BA1202 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05163041
Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression treatment 1 / 2 recruiting NCT05118841
Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT03856541
A Study of SHR-A1403 in Patients With Advanced Solid Tumor No drug interventions treatment 1 completed NCT05720117
Study of PYX-201 in Solid Tumors treatment 1 recruiting NCT05434234
A Study of YL201 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05144334
A Study of BTX-1188 in Subjects With Advanced Malignancies No drug interventions treatment 1 terminated NCT05620134
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT06028724
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) No drug interventions Not Available Not Available recruiting NCT04338724
A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT06299124
A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT06487624
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors treatment 1 not_yet_recruiting NCT06208124
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05269316
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03182816
CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT04348916
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors treatment 1 terminated NCT06512116
A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients. No drug interventions treatment 1 not_yet_recruiting NCT05532696
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients No drug interventions treatment 1 / 2 recruiting NCT05101096
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05525858
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II Not Available Not Available recruiting NCT06298058
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients. No drug interventions treatment 1 not_yet_recruiting NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) treatment 2 active_not_recruiting NCT04855435
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT05388435
Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients treatment 1 / 2 terminated NCT05840835
Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06421935
M9466 as Single Agent or in Combination With Tuvusertib in Advanced Solid Tumors (DDRiver 501) treatment 1 recruiting NCT04337463
ATG-008 Combined With Toripalimab in Advanced Solid Tumors treatment 1 / 2 unknown_status NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma treatment 1 completed NCT06470763
A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1) treatment 1 / 2 recruiting NCT05824663
A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05841563
Clinical Trial of PM54 in Advanced Solid Tumors Patients. No drug interventions treatment 1 recruiting NCT05781386
A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors treatment 1 recruiting NCT04751786
Dose Escalation Study of Immunomodulatory Nanoparticles No drug interventions treatment 1 recruiting NCT04990739
Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04941339
A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors treatment 1 unknown_status NCT04145622
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors treatment 1 / 2 recruiting NCT06057922
A Study YL201 in Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04381325
A Study of MSB0254 Injection in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT06307925
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05148325
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02168725
Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors treatment 1 terminated NCT02133625
A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors treatment 1 completed NCT06253130
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04431830
Meaning-Centered Pain Coping Skills Training No drug interventions supportive_care Not Available completed NCT05877430
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT05836948
The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05300048
Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations treatment 1 active_not_recruiting NCT05599048
Hyperpolarized 13C Pyruvate as a Biomarker in Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05341557
A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma No drug interventions treatment 1 not_yet_recruiting NCT06302426
Trial of INI-4001 in Patients With Advanced Solid Tumours treatment 1 not_yet_recruiting NCT05948826
First in Human Study of TORL-3-600 in Participants With Advanced Cancer No drug interventions treatment 1 recruiting NCT04442126
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT04247126
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors treatment 1 completed NCT04872166
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer No drug interventions treatment 1 recruiting NCT05385965
Meaning-Centered Pain Coping Skills Training for Cancer Pain No drug interventions supportive_care Not Available recruiting NCT05933265
Study of LP-184 in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05791474
ATI-2231 in Advanced Solid Tumor Malignancies No drug interventions treatment 1 withdrawn NCT05868174
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors treatment 1 recruiting NCT04802174
Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers treatment 1 / 2 recruiting NCT05320874
A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. No drug interventions treatment 1 not_yet_recruiting NCT02189174
Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies No drug interventions treatment 1 terminated NCT05585320
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT05372120
A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations No drug interventions treatment 2 recruiting NCT06205082
A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor No drug interventions treatment 1 enrolling_by_invitation NCT06345482
A Study of MHB039A for Advanced Solid Tumor No drug interventions treatment 1 / 2 not_yet_recruiting NCT01877382
A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas treatment 1 completed NCT04282031
A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer treatment 1 / 2 recruiting NCT04682431
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 terminated NCT03666273
Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1. treatment 1 completed NCT04162327
A Phase Ia/Ib Study of IBI315 in Patients With HER2-expressing Advanced Solid Tumor No drug interventions treatment 1 completed NCT05744427
To Evaluate the Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05766527
A Study of KM602 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04108676
Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects other 1 completed NCT04104776
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 / 2 recruiting NCT01195376
A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors treatment 1 completed NCT04233060
A Study of CS3005 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT05263960
A Study of CM350 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05801094
A Phase I Study of QL1604 for Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06172894
PBMC-based Leukocyte Immunotherapy No drug interventions treatment 1 recruiting NCT06170294
MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06289894
A Study of BRY805 in Participants With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05036291
A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06154291
FIH XON7 in Advanced/Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05878691
A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. treatment 1 active_not_recruiting NCT05265091
A Study of KL590586 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05932862
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05971862
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT05204862
Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03941262
Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy treatment 1 completed NCT05906862
AMT-253 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT00449280
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies treatment 1 completed NCT04855929
A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients With Advanced Cancer. treatment 1 recruiting NCT05438329
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04772989
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies treatment 1 active_not_recruiting NCT06072989
Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors No drug interventions treatment 1 recruiting NCT05578092
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway treatment 1 / 2 recruiting NCT04825392
A Phase Ib Study of HX008 in Patients With Advanced Solid Tumors treatment 1 unknown_status NCT04272944
A Study of MSB2311 in Advanced Solid Tumors No drug interventions treatment 1 completed NCT06463340
Study of SGR-3515 In Participants With Advanced Solid Tumors. No drug interventions treatment 1 recruiting NCT06480240
A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04349267
Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT04513067
A Safety Study of YQ23 in Advanced Solid Tumors Patients treatment 1 terminated NCT05021367
A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor No drug interventions treatment 1 active_not_recruiting NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT04761601
First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors treatment 1 terminated NCT04162301
A Study of CS3002 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT05884801
Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06112704
HS-20093 in Patients With Advanced Esophageal Carcinoma and Other Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT05052268
XTX202 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05539768
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor treatment 0 not_yet_recruiting NCT03466268
Study to Evaluate the Safety and Anti-tumor Activity of SCC244 treatment 1 unknown_status NCT05048368
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function No drug interventions treatment 1 not_yet_recruiting NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy treatment 1 / 2 recruiting NCT05278546
A Study of ILB2109 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT05231746
A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001) treatment 1 completed NCT03704246
Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors treatment 2 unknown_status NCT05103046
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06228846
An Phase I Study of YY001 in Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05479812
Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT05309512
Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT06519110
Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations treatment 2 not_yet_recruiting NCT06497010
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment treatment 0 recruiting NCT04056910
Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors treatment 2 completed NCT04116710
A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors treatment 1 completed NCT06237881
A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors treatment 1 / 2 recruiting NCT01353781
Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies treatment 1 completed NCT05915481
Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors treatment 1 / 2 not_yet_recruiting NCT06253195
BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors treatment 1 recruiting NCT04836195
Phase I Trial of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma treatment 1 recruiting NCT05495295
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT04801095
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05148195
A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors treatment 2 terminated NCT02977195
First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 completed NCT00739414
Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors treatment 1 completed NCT04118114
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT04934514
Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors treatment 1 / 2 recruiting NCT04905914
Study Of ATRN-119 In Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05251714
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer treatment 1 / 2 recruiting NCT06260514
Study of APR-1051 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05525455
TT-816 as Monotherapy or in Combination With a PD-1 Inhibitor in Patients With Advanced Cancers (SEABEAM) (MK3475-E88) No drug interventions treatment 1 / 2 terminated NCT05052255
RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06487455
A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. No drug interventions treatment 1 recruiting NCT05985655
Study to Assess GTAEXS617 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03871855
A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors treatment 1 terminated NCT05772455
A Study of XZB-0004 in Patients With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05979155
A Study of NWY001 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06171750
Phase I Study of ANK-101 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06108050
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors treatment 1 recruiting NCT04259450
Study to Assess AFM24 in Advanced Solid Cancers No drug interventions treatment 1 / 2 completed NCT05352750
Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02278250
First in Human Study of M4344 in Participants With Advanced Solid Tumors treatment 1 completed NCT04721223
JAB-3068 Activity in Adult Patients With Advanced Solid Tumors treatment 1 / 2 unknown_status NCT06258408
A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06232408
LIONS (PLK4 Inhibitor in Advanced Solid Tumors) No drug interventions treatment 1 recruiting NCT05205408
A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04383938
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies treatment 1 / 2 completed NCT05673538
TT-00973-MS Tablets in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05354843
SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05183243
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results No drug interventions treatment 1 recruiting NCT06431243
A Clinical Study of Puesta Mesylate for Injection in Patients With Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT05490043
A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas treatment 1 recruiting NCT05981703
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors treatment 1 recruiting NCT03028103
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients treatment 1 completed NCT06132503
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors treatment 1 recruiting NCT04049903
Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05156203
Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04495790
AIMS Cancer Outcomes Study No drug interventions Not Available Not Available recruiting NCT05465590
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer No drug interventions treatment 0 withdrawn NCT03330990
Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients other 1 completed NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06220864
SNV1521 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05911464
A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01131364
Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients treatment 1 / 2 terminated NCT05205421
A Study of Oncolytic Virus Injection (RT-01) in Patients With Extensive-Stage Small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT06302621
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors treatment 1 recruiting NCT01387321
A Study of BYL719 in Adult Patients With Advanced Solid Malignancies treatment 1 completed NCT06187402
A Study of LM-24C5 For Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04502602
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer treatment 1 recruiting NCT05789602
A Study of BPI-460372 in Advanced Solid Tumor Patients No drug interventions treatment 1 recruiting NCT05451602
HEC169096 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03994484
Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets No drug interventions treatment 1 unknown_status NCT05255484
Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours No drug interventions treatment 1 / 2 terminated NCT04557384
A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer treatment 1 terminated NCT05073484
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients No drug interventions treatment 1 terminated NCT05819684
A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT04592484
A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors No drug interventions treatment 1 / 2 completed NCT03604679
SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors treatment 1 completed NCT06169579
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers No drug interventions treatment 1 enrolling_by_invitation NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05271279
A Study of OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors No drug interventions treatment 0 terminated NCT06566079
Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06182579
Phase I Study of RiMO-401 With Radiation in Advanced Tumors No drug interventions treatment 1 recruiting NCT03260179
Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810 No drug interventions treatment 1 unknown_status NCT02884479
An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study treatment 1 / 2 unknown_status NCT05263479
A Study of HS-20089 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04443686
5-aminolevulinic Acid In Advanced Malignancies No drug interventions treatment 1 recruiting NCT05560191
PY265 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT02160106
First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors treatment 1 completed NCT06255665
A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors No drug interventions treatment 1 recruiting NCT03309150
ATRi Transition Rollover Study treatment 1 active_not_recruiting NCT01859351
Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours No drug interventions treatment 1 terminated NCT02617277
Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours treatment 1 active_not_recruiting NCT02588105
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer treatment 1 completed NCT02430311
The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour. treatment 1 completed NCT04462952
Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours other 1 completed NCT03518606
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours treatment 1 / 2 active_not_recruiting NCT04742036
Capivasertib China PK Study treatment 1 completed NCT03101839
Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours No drug interventions treatment 1 completed NCT05647122
First in Human Study of AZD9592 in Solid Tumors treatment 1 recruiting NCT03486730
BT1718 in Patients With Advanced Solid Tumours. No drug interventions treatment 1 / 2 completed NCT05804526
A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours treatment 1 / 2 recruiting NCT02579226
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors. No drug interventions treatment 1 completed NCT04564027
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer treatment 2 active_not_recruiting NCT05701527
A Study of EBC-129 in Advanced Solid Tumours treatment 1 recruiting NCT01581060
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours No drug interventions treatment 1 / 2 terminated NCT01585701
Phase I Study of AT13148, a Novel AGC Kinase Inhibitor No drug interventions treatment 1 completed NCT04504669
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours treatment 1 active_not_recruiting NCT02042781
Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours No drug interventions treatment 1 completed NCT01252095
Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours No drug interventions treatment 1 terminated NCT03852823
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours No drug interventions treatment 1 unknown_status NCT01058538
A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours treatment 1 / 2 completed NCT03507543
The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors treatment 1 completed NCT01163903
Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours treatment 1 completed NCT05537051
A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours No drug interventions treatment 1 not_yet_recruiting NCT04907851
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) treatment 2 completed NCT03421353
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer treatment 1 completed NCT03508011
A Study of IMP4297 in Patients With Advanced Solid Tumors treatment 1 completed NCT01194193
Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours treatment 1 withdrawn NCT02341456
Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours treatment 1 completed NCT05514132
A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours treatment 1 active_not_recruiting NCT02389842
PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib treatment 1 unknown_status NCT05508334
A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT06380816
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT04949425
A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours treatment 1 terminated NCT04959266
A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib other 1 terminated NCT04434482
IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer treatment 1 / 2 recruiting NCT03746431
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection No drug interventions treatment 1 / 2 recruiting NCT05154604
A Study of SHR-A1921 for Injection in Subjects With Advanced Solid Tumours No drug interventions treatment 1 unknown_status NCT04946968
Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers treatment 2 recruiting NCT03150368
Extended Use of ModraDoc006/r treatment 1 completed NCT01668550
A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours treatment 1 terminated NCT05920408
Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours No drug interventions treatment 1 / 2 terminated NCT01305512
Pharmacokinetic, Safety and Tolerability Study of SPARC1028 No drug interventions treatment 1 completed NCT01304303
Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination No drug interventions treatment 1 completed NCT03330106
A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors other 1 completed NCT03061188
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma treatment 1 completed NCT03486314
A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors other 1 completed NCT03708211
A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors other 1 completed NCT02829099
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors treatment 1 completed NCT02525536
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors treatment 1 completed NCT03338881
A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies No drug interventions other 1 withdrawn NCT03359733
A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor No drug interventions other 1 withdrawn NCT03742895
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002) treatment 2 recruiting